Global Gamma Probe Devices Market Insights
A gamma probe device is a non-invasive medical device used for interstitial injection of a radionuclide. This device is primarily used to locate sentinel lymph nodes for breast cancer treatment, and is also used in parathyroid surgery. Gamma probe devices are enabling surgeons operate in radio-guided diagnosis and surgery during intra-operation and pre-operation.
It is often difficult to locate tissues such as lymph nodes, tumours, and parathyroid glands within the human body for surgeons. Consequently, the utilization of gamma probe devices in a proper way could facilitate surgeons to go for a smaller incision to locate the tissues of interest.
Due to their primary use for sentinel lymph node mapping and diagnosis of thyroid disease, the gamma probe devices market size is expected to experience noteworthy expansion over the forecast period of 2020 to 2030.
Request Sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=5110
Increasing investments in the gamma probe devices market by major players and rising emphasis on low-cost product development are major factors expected to boost market growth. The sales of gamma probe devices market was valued at US$ 67 Mn in 2019, and is expected to exhibit a CAGR of around 10% during the forecast period (2020–2030).
Key Trends of Gamma Probe Devices Market
- The trolley-mounted devices segment, by modality, held maximum value share in the global gamma probe devices market in 2019, owing to their growing preference in hospitals due to convenient localization during surgery.
- By application, the sentinel lymph node uptake segment holds a notable revenue share of around 57% in the global gamma probe devices market, owing to the primary use of sentinel lymph node mapping to locate small and non-palpable breast lesions.
- North America and Europe collectively hold around 70% of the market share, owing to rapid new product launches in these regions.
- In terms of end user, hospitals are expected to dominate the global gamma probe devices market during the forecast period.
- High patient population and increasing government support towards advancing healthcare in Asian countries are expected to propel the growth of the gamma probe devices market in the region.
- The COVID-19 outbreak has thrown most economies and sectors off track. Supply chain disruptions due to manpower shortage and movement restrictions are hampering the progress of the global gamma probe devices market.
Request Methodology – https://www.factmr.com/connectus/sample?flag=RM&rep_id=5110
Key Segments of Gamma Probe Devices Market
Fact.MR’s study on the gamma probe devices market offers information divided into four important segments – modality, application, end-user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Modality
- Handheld Devices
- Benchtop Devices
- Trolley-mounted Devices
Application
- Thyroid Uptake
- Sentinel Lymph Node Uptake
- Breast Cancer
- Melanoma
- Colon Cancer
- NSCLC
- Renal Cancer
- Others
Buy Now – https://www.factmr.com/checkout/5110
Incresing Consolidation among Key Players and Technology Advancements
Increase in market consolidation activities among market players, including collaborations, partnerships, acquisitions, and mergers are the characteristic of the overall competition among global gamma probe devices market players. Manufacturers are also focusing on introducing advanced gamma probe devices to support clinicians in simplifying their diagnostic and surgical procedures. For instance, in March 2018, Hologic Inc. entered into a partnership with Philips to provide integrated imaging solutions for women’s health.
For More Insights- https://www.biospace.com/article/increasing-demand-for-phage-probiotics-driving-bacteriophage-market-fact-mr/
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
